Health and Me

Rachel V Thomas

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Danish pharma giant Novo Nordisk has once again reduced the prices of its blockbuster drugs Ozempic and Wegovy in India. The strategic move is aimed at staying ahead of the entry of the low-cost generic competition in the country.

Starting today, the Ozempic price in India will be cut by 36 percent, while Wegovy has seen a steeper 48 percent reduction — limiting the base price below Rs 6,000 per month.

While Ozempic is available in three dose strengths of 0.25 mg, 0.5 mg, and 1 mg in India, Wegovy has five dose strengths. 

Ozempic's and Wegovy's lowest doses of 0.25 ⁠mg will now be priced at Rs 1,415 for a weekly shot from Rs 2,200 and Rs 2,712 earlier, respectively, Novo Nordisk India said in a statement on Tuesday. 

The average price reduction across doses is 23.8 percent for Ozempic and 27 percent for Wegovy, it added. 

Speaking to the media, <a href="https://www.healthandme.com/health-news/novo-nordisk-and-hims-hers-health-end-dispute-plan-to-sell-wegovy-together-article-153776417" data-type="tilCustomLink">Novo Nordisk</a> stated that the price cut will benefit a large section of people with diabetes and obesity in India.

The generic weight loss drugs will open up a huge customer base, especially in India, with a high burden of diabetes and obesity.

Novo first slashed Wegovy's price for the first time by up to 37 percent from its launch price last year.

In addition to the entry of generics, the launch of rival Eli Lilly's blockbuster diabetes and obesity drug Mounjaro in India in 2025.

Also read: <a href="https://www.healthandme.com/health-news/semaglutide-becomes-cheap-in-india-a-gamechanger-or-health-gamble-article-153890116" data-type="tilCustomLink">Semaglutide Becomes Cheap In India: A Gamechanger Or Health Gamble?</a> <h2></h2>

Soon after the end of Novo Nordisk's patent on semaglutide, on March 20, a host of companies in India launched generic versions of Ozempic.

This includes <a href="https://www.healthandme.com/health-news/natco-pharmas-1st-to-launch-generic-semaglutide-in-india-prices-start-from-rs-1290-article-153883910" data-type="tilCustomLink">NATCO Pharma's</a> Semanat and Semafull, priced at Rs 1,290 per month and Rs 1,750 — about 90 per cent cheaper than Ozempic, costing Rs 8,800 per month.

Eris Lifesciences also announced its plans to launch a multi-dose vial under the brand name Sundae at the same price.

Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, and Glenmark Pharmaceuticals have also launched their generic versions of semaglutide.

Dr. Reddy’s Obeda is priced at Rs 4,200 per month, available in 2 mg and 4 mg strengths. 

Sun Pharmaceutical Industries will sell under the brand names Noveltreat (doses ranging from Rs 900) and Sematrinity (doses ranging from Rs 750). Meanwhile, Glenmark’s GLIPIQ vials range from Rs 325 to Rs 440 per week. 

Zydus Lifesciences has also announced the launch of its generic version of semaglutide injection under the brand names SEMAGLYNTM, MASHEMATM, and ALTERMET. The average monthly cost of the treatment will be about Rs 2,200, the company said in a statement. 

<a href="https://www.healthandme.com/health-news/alkem-laboratories-launches-cheapest-semaglutide-injection-in-india-article-153892976" data-type="tilCustomLink">Alkem Laboratories</a>' semaglutide injection is priced merely at a weekly cost of Rs 450 — making it one of the cheapest options available in the market.

Semaglutide works as a GLP-1 receptor agonist that mimics the GLP-1 hormone to regulate appetite and blood sugar. It slows gastric emptying and makes you feel fuller longer. It also signals the brain to reduce hunger and cravings, and triggers the pancreas to release insulin when blood sugar is high. 

Also read: <a href="https://www.healthandme.com/health-wellness/this-pill-is-more-effective-for-weight-loss-than-ozempic-scientists-say-article-153949348" data-type="tilCustomLink">This Pill Is More Effective For Weight Loss Than Ozempic, Scientists Say</a>

They work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake. 

In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and the body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate the pancreas to release insulin and suppress the release of another hormone called glucagon. 

These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.

Health Conditions A-Z

health

ozempic-and-wegovy-prices-slashed-again-in-india-to-counter-cheaper-generics

ozempic

Novo Nordisk

Wegovy

ozempic and wegovy

Generics

Sun Pharmaceutical

GLP 1

Semaglutide

breast-conservation-surgery-vs-mastectomy-what-surgeons-recommend-today

Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

leptospirosis-us-health-officials-flag-outbreak-risk-after-floods-in-hawaii

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Health News

8 Sit-Up Variations to Strengthen Your Core and Build Stability

Benefits Of Ayurvedic Health Supplement Ashwagandha

9 Anti-Inflammatory Breakfast Options You Should Try

5 Foods You Should Avoid For PCOS, Says Gynecologist

Love Sitting With Your Legs Crossed? Here’s You Should Avoid It

6 Daily Foods That Are Secretly Increasing Your Calories

9 Brain Boosters You Should Do Everyday

Hip Exercises That Will Keep You Flexible As You Age

9 Leg Exercises Office Workers’ Should Do At Home

Benefits of Having Herbal Tea Every Morning

9 Daily Habits That Boost Your Brain Power

Lower-Body Exercises That Are Game-Changers

How Drinking Apple Cider Vinegar Helps You

Aging Myths You Should Never Believe

Superfoods That Support Your Gut Health

What Happens To Your Body When You Eat Instant Noodles Every Day?

Health Issues Premature Babies Often Face

Exercises Office Workers Should Do For Their Heart Health

Reasons Why You Should Add Raw Turmeric To Your Diet

Benefits Of Drinking Milk At Night: Why You Should Do It

Food That Provides Vitamin B12 Naturally In Your Diet

Surprising Health Benefits Of Fenugreek Seeds

9 Superfoods You Should Eat For Your Brain Health

What Does Mental Health Support Look Like At Work?

Long Stretches You Should Do To Unwind From Your Day

Colon Cancer In Young Adults: Early Symptoms You Should Know

Health Benefits Of Eating Dry Fruits Everyday

Are You At Risk For Fried Rice Syndrome?

These Tests Reveal How Well You Are Aging

Lower-Back Exercises You Should Do After A Long-Day's Work

Children’s Diet – What Kids Need To Eat For Immunity Building

Common Diabetes Myths That Could Hurt Your Health

Love Spicy Food? Here’s How It Affects Your Health

Superfood List: Veggies And Fruits You Must Have For Immunity

Foods People With IBS Should Avoid

Exercises To Improve Digestion

Easy Work Lunches You Can Make In The Morning

Hunger Vs Craving: Difference Explained In 60 seconds

These Things Can Cause Your Heart To Age Faster

High Carb Foods That Are Actually Healthy

Danish pharma giant Novo Nordisk has once again reduced the prices of its blockbuster drugs Ozempic and Wegovy in India. The strategic move is aimed at staying ahead of the entry of the low-cost generic competition in the country.Starting today, the Ozempic price in India will be cut by 36 percent, while Wegovy has seen a steeper 48 percent reduction — limiting the base price below Rs 6,000 per month. While Ozempic is available in three dose strengths of 0.25 mg, 0.5 mg, and 1 mg in India, Wegovy has five dose strengths. Ozempic's and Wegovy's lowest doses of 0.25 ⁠mg will now be priced at Rs 1,415 for a weekly shot from Rs 2,200 and Rs 2,712 earlier, respectively, Novo Nordisk India said in a statement on Tuesday. The average price reduction across doses is 23.8 percent for Ozempic and 27 percent for Wegovy, it added. Speaking to the media, Novo Nordisk stated that the price cut will benefit a large section of people with diabetes and obesity in India. The generic weight loss drugs will open up a huge customer base, especially in India, with a high burden of diabetes and obesity.Novo first slashed Wegovy's price for the first time by up to 37 percent from its launch price last year.In addition to the entry of generics, the launch of rival Eli Lilly's blockbuster diabetes and obesity drug Mounjaro in India in 2025. Also read: Semaglutide Becomes Cheap In India: A Gamechanger Or Health Gamble? Entry Of Generics In India Soon after the end of Novo Nordisk's patent on semaglutide, on March 20, a host of companies in India launched generic versions of Ozempic. This includes NATCO Pharma's Semanat and Semafull, priced at Rs 1,290 per month and Rs 1,750 — about 90 per cent cheaper than Ozempic, costing Rs 8,800 per month. Eris Lifesciences also announced its plans to launch a multi-dose vial under the brand name Sundae at the same price.Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, and Glenmark Pharmaceuticals have also launched their generic versions of semaglutide. Dr. Reddy’s Obeda is priced at Rs 4,200 per month, available in 2 mg and 4 mg strengths. Sun Pharmaceutical Industries will sell under the brand names Noveltreat (doses ranging from Rs 900) and Sematrinity (doses ranging from Rs 750). Meanwhile, Glenmark’s GLIPIQ vials range from Rs 325 to Rs 440 per week. Zydus Lifesciences has also announced the launch of its generic version of semaglutide injection under the brand names SEMAGLYNTM, MASHEMATM, and ALTERMET. The average monthly cost of the treatment will be about Rs 2,200, the company said in a statement. Alkem Laboratories' semaglutide injection is priced merely at a weekly cost of Rs 450 — making it one of the cheapest options available in the market.How Does Semaglutide Work? Semaglutide works as a GLP-1 receptor agonist that mimics the GLP-1 hormone to regulate appetite and blood sugar. It slows gastric emptying and makes you feel fuller longer. It also signals the brain to reduce hunger and cravings, and triggers the pancreas to release insulin when blood sugar is high. Also read: This Pill Is More Effective For Weight Loss Than Ozempic, Scientists SayThey work by increasing insulin release in a glucose-dependent manner, decreasing the liver's production of glucagon, and slowing down the emptying of the stomach, which helps lower blood sugar levels after a meal. They also act on the brain to suppress appetite and increase feelings of fullness, leading to reduced calorie intake. In people with type 2 diabetes, notes Harvard Health, the body's cells are resistant to the effects of insulin and the body does not produce enough insulin, or both. This is when GLP-1 agonists stimulate the pancreas to release insulin and suppress the release of another hormone called glucagon. These drugs also act in the brain to reduce hunger and act on the stomach to delay emptying, so you feel full for a longer time. These effects can lead to weight loss, which can be an important part of managing diabetes.

ozempic and wegovy prices slashed again in india to counter cheaper generics

About Us

Contact Us

Terms & Conditions

Privacy Policy

Company

Health and Me is a premium website with content written and curated to function as a handbook for all Health concerns.

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Cicada COVID Variant: Use Masks To Avoid Transmission, Say Experts

Tpoxx Should No Longer Be Used For Treating Mpox: European Drug Regulator

Health Conditions A-Z

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Cicada COVID Variant: Use Masks To Avoid Transmission, Say Experts

​Tpoxx Should No Longer Be Used For Treating Mpox: European Drug Regulator

Health Conditions A-Z

Ozempic And Wegovy Prices Slashed Again In India To Counter Cheaper Generics

Breast Conservation Surgery vs Mastectomy: What Surgeons Recommend Today

Leptospirosis: US health officials flag outbreak risk after floods in Hawaii

Tpoxx Should No Longer Be Used For Treating Mpox: European Drug Regulator